SKI Market

A+| A| A-|

Indian Indices

Sensex

77,781.61 -734.88
( -0.94%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

21.89

101577.75

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.66

Back

Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter

Jan 21,2026

Net profit of Dr Reddy's Laboratories declined 14.42% to Rs 1209.90 crore in the quarter ended December 2025 as against Rs 1413.70 crore during the previous quarter ended December 2024. Sales rose 4.41% to Rs 8727.00 crore in the quarter ended December 2025 as against Rs 8358.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8727.00	8358.60	4
OPM %	21.63	27.19	-
PBDT	2064.20	2345.70	-12
PBT	1543.20	1874.30	-18
NP	1209.90	1413.70	-14

77,781.61 -734.88 ( -0.94%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)